• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    ICL Reports First Quarter 2025 Results

    5/19/25 1:10:00 AM ET
    $ICL
    Agricultural Chemicals
    Industrials
    Get the next $ICL alert in real time by email

    Sales of $1.8 billion increased year-over-year, with operating income of $185 million, adjusted EBITDA of $359 million and adjusted diluted EPS of $0.09

    ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the first quarter ended March 31, 2025. Consolidated sales were $1.8 billion versus $1.7 billion in the prior year. Operating income was $185 million versus $203 million of operating income in the first quarter of last year, with adjusted operating income of $208 million versus $215 million. For the first quarter, net income attributable to shareholders was $91 million versus $109 million in the prior year, with adjusted net income of $110 million compared to $118 million. Adjusted EBITDA was $359 million versus $362 million. Diluted earnings per share were $0.07 versus $0.08 in the first quarter of last year, with adjusted diluted EPS of $0.09 – the same as in the first quarter of last year.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250517057266/en/

    "ICL delivered sequential increases in first quarter sales, adjusted EBITDA and EPS, with results led by our specialties-driven businesses. Our Industrial Products, Phosphate Solutions and Growing Solutions businesses also reported year-over-year growth in sales and EBITDA, generally driven by higher volumes with limited price improvement. For our Potash segment, prices were lower year-over-year, as expected, with supply more heavily weighted toward our annual 2024 contracts with China and India, which are at lower prices than current market rates," said Elad Aharonson, president and CEO of ICL. "Looking forward, we expect to benefit from our existing distinctive global presence, as the industry awaits additional clarity regarding global tariff and trade negotiations. We plan to rely on our regionally diversified operations and will also continue to focus on specialties solutions for our global customers on a local basis using local production."

    The company reiterates its guidance for full year 2025, with specialties-driven EBITDA of between $0.95 billion to $1.15 billion and Potash sales volumes of between 4.5 million and 4.7 million metric tons. (1a)

    Key Financials

    First Quarter 2025

    US$M

    Ex. per share data

    1Q'25

    1Q'24

    Sales

    $1,767

    $1,735

    Gross profit

    $560

    $557

    Gross margin

    32%

    32%

    Operating income

    $185

    $203

    Adjusted operating income (1)

    $208

    $215

    Operating margin

    10%

    12%

    Adjusted operating margin (1)

    12%

    12%

    Net income attributable to shareholders

    $91

    $109

    Adjusted net income attributable to shareholders (1)

    $110

    $118

    Adjusted EBITDA (1)

    $359

    $362

    Adjusted EBITDA margin (1)

    20%

    21%

    Diluted earnings per share

    $0.07

    $0.08

    Diluted adjusted earnings per share (1)

    $0.09

    $0.09

    Cash flows from operating activities (2)

    $165

    $292

    (1)

    Adjusted operating income and margin, adjusted net income attributable to shareholders, adjusted EBITDA and margin, and diluted adjusted earnings per share are non-GAAP financial measures. Please refer to the adjustments table and disclaimer.

    (2)

    See "Condensed consolidated statements of cash flows (unaudited)" in the appendix below.

    Industrial Products

    First quarter 2025

    • Sales of $344 million vs. $335 million.
    • EBITDA of $76 million vs. $72 million.
    • Year-over-year growth driven by better volumes in flame retardants.

    Key developments versus prior year

    • Flame retardants: Overall sales increased, with bromine-based product sales up slightly, as higher volumes offset lower prices. Sales of phosphorous-based solutions increased, with higher volumes mainly in Europe and the U.S., and overall higher prices. Both the electronics and construction end-markets remained somewhat soft, in the first quarter.
    • Elemental bromine: Higher volumes drove an increase in sales, offsetting lower market prices.
    • Clear brine fluids: Sales lower, despite solid trends and continued strength in oil and gas demand in the Gulf of America, while competition increased in the Eastern Hemisphere.
    • Specialty minerals: A slight increase in sales was driven by higher volumes and prices for magnesium chloride used in deicing, while there was a decrease in specialty magnesia demand for pharma and food applications.

    Potash

    First quarter 2025

    • Sales of $405 million vs. $423 million.
    • EBITDA of $118 million vs. $124 million.
    • Grain Price Index decreased 12.1% year-over-year, with corn up 9.1%, while rice, soybeans and wheat were down 22.2%, 15.1% and 8.1%, respectively. On a sequential basis, the Grain Price Index increased 1.0%, with corn, soybeans and wheat up 10.5%, 3.3%, 4.5%, respectively, while rice declined 6.8%.

    Key developments versus prior year

    • Potash price: $300 per ton (CIF).
      • Up 5% sequentially but down 7% year-over-year.
      • ICL continued to fulfill its 2024 annual contracts with China and India, and the prices in these agreements were lower than market rates, which improved as the first quarter progressed.
    • Potash sales volumes: 1,103 thousand metric tons.
      • Increased by 19 thousand metric tons year-over-year, with higher volumes mainly to Brazil and China.
    • ICL Dead Sea
      • Production decreased, with continued operational challenges primarily related to external forces.
    • ICL Iberia
      • Production lower, while efficiency efforts remain on-track.

    Phosphate Solutions

    First quarter 2025

    • Sales of $573 million vs. $559 million.
    • EBITDA of $139 million vs. $131 million.
    • Year-over-year growth driven by strength in commodities, while specialties results were lower but in-line with market dynamics.

    Key developments versus prior year

    • White phosphoric acid: Sales increased, as strong volume growth in all regions offset lower prices.
    • Industrial phosphates: Sales increased, as higher volumes in all major regions offset lower prices related to decreasing cost inputs.
    • Food phosphates: Despite higher volumes, sales decreased due to lower market prices, which reflected reduced raw material costs.
    • Battery materials: Sales decreased, as higher prices in China were unable to offset lower volumes. In January, ICL signed a strategic agreement with Shenzhen Dynanonic to establish battery materials production in Europe, and in early April, the company formally commissioned its Battery Materials Innovation and Qualification (BMIQ) Center in St. Louis.
    • Commodity phosphates: Overall phosphate prices were stable to higher, as global demand remained firm and as China continued to restrict exports.

    Growing Solutions

    First quarter 2025

    • Sales of $495 million vs. $479 million.
    • EBITDA of $47 million vs. $42 million.
    • Continued focus on innovative, regional solutions helped drive year-over-year growth.

    Key developments versus prior year

    • Brazil: Sales increased on both higher volumes and prices, however, product mix and exchange rate fluctuations caused a decrease in gross profit.
    • Europe: Sales decreased on lower volumes, but gross profit increased, due to higher prices and improved product mix.
    • North America: Sales increased, with higher volumes – in part due to the 2024 acquisition of Custom Ag Formulators – and slightly higher prices contributing to increased gross profit.
    • Asia: Sales increased, as higher volumes drove higher gross profit.
    • Product trends: Specialty agriculture sales increased on both higher volumes, in Europe, the U.S., China and Brazil, and higher prices – mainly in Brazil. Turf and ornamental sales increased, with turf and landscape experiencing both higher volumes and prices, while ornamental horticulture volumes declined in the U.S. and China.
    • In early April, ICL acquired a leading ag-biologicals company, and this acquisition further advanced the company's stated goal of expanding its Growing Solutions product offerings and to position the business for further growth in new and adjacent end-markets.

    Financial Items

    Financing Expenses

    Net financing expenses for the first quarter of 2025 were $37 million, up versus $35 million in the corresponding quarter of last year.

    Tax Expenses

    Reported tax expenses in the first quarter of 2025 were $42 million, reflecting an effective tax rate of 28%, compared to $42 million in the corresponding quarter of last year, reflecting an effective tax rate of 25%.

    Available Liquidity

    ICL's available cash resources, which are comprised of cash and deposits, unutilized revolving credit facility, and unutilized securitization, totaled $1,491 million, as of March 31, 2025.

    Outstanding Net Debt

    As of March 31, 2025, ICL's net financial liabilities amounted to $1,993 million, an increase of $142 million compared to December 31, 2024.

    Dividend Distribution

    In connection with ICL's first quarter 2025 results, the Board of Directors declared a dividend of 4.26 cents per share, or approximately $55 million, versus 4.57 cents per share, or approximately $59 million, in the first quarter of last year. The dividend will be payable on June 18, 2025, to shareholders of record as of June 4, 2025.

    About ICL

    ICL Group Ltd. is a leading global specialty minerals company, which creates impactful solutions for humanity's sustainability challenges in the food, agriculture and industrial markets. ICL leverages its unique bromine, potash and phosphate resources, its global professional workforce, and its sustainability focused R&D and technological innovation capabilities, to drive the company's growth across its end markets. ICL shares are dual listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The company employs more than 12,000 people worldwide, and its 2024 revenue totaled approximately $7 billion.

    For more information, visit ICL's website at icl-group.com.

    To access ICL's interactive CSR report, visit icl-group-sustainability.com.

    You can also learn more about ICL on Facebook, LinkedIn, YouTube, X and Instagram.

    Guidance

    (1a) The company only provides guidance on a non-GAAP basis. The company does not provide a reconciliation of forward-looking adjusted EBITDA (non-GAAP) to GAAP net income (loss), due to the inherent difficulty in forecasting, and quantifying certain amounts that are necessary for such reconciliation, in particular, because special items such as restructuring, litigation, and other matters, used to calculate projected net income (loss) vary dramatically based on actual events, the company is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income (loss) at this time. The amount of these deductions may be material, and therefore could result in projected GAAP net income (loss) being materially less than projected adjusted EBITDA (non-GAAP). The guidance speaks only as of the date hereof. The company undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. The company provides guidance for specialties-driven EBITDA, which includes Industrial Products, Growing Solutions and Phosphate Solutions, as the Phosphate Solutions business is now predominantly specialties focused. For the Potash business, the company is providing sales volume guidance. The company believes this information provides greater transparency, as these new metrics are less impacted by fertilizer commodity prices, given the extreme volatility in recent years.

    Non-GAAP Statement

    The company discloses in this quarterly report non-IFRS financial measures titled adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA. Management uses adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA to facilitate operating performance comparisons from period to period. The company calculates adjusted operating income by adjusting operating income to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating, and net income (non-GAAP)" below. Certain of these items may recur. The company calculates adjusted net income attributable to the company's shareholders by adjusting net income attributable to the company's shareholders to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating, and net income (non-GAAP)" below, excluding the total tax impact of such adjustments. The company calculates diluted adjusted earnings per share by dividing adjusted net income by the weighted-average number of diluted ordinary shares outstanding. Adjusted EBITDA is calculated as net income before financing expenses, net, taxes on income, share in earnings of equity-accounted investees, depreciation and amortization, and certain adjustments presented in the reconciliation table under "Consolidated adjusted EBITDA, and diluted adjusted earnings per share for the periods of activity" below, which were adjusted for in calculating the adjusted operating income.

    You should not view adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share or adjusted EBITDA as a substitute for operating income or net income attributable to the company's shareholders determined in accordance with IFRS, and you should note that the company's definitions of adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA may differ from those used by other companies. Additionally, other companies may use other measures to evaluate their performance, which may reduce the usefulness of the company's non-IFRS financial measures as tools for comparison. However, the company believes adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA provide useful information to both management, and investors by excluding certain items that management believes are not indicative of ongoing operations. Management uses these non-IFRS measures to evaluate the company's business strategies and management performance. The company believes these non‑IFRS measures provide useful information to investors because they improve the comparability of financial results between periods and provide for greater transparency of key measures used to evaluate performance.

    The company presents a discussion in the period-to-period comparisons of the primary drivers of change in the company's results of operations. This discussion is based in part on management's best estimates of the impact of the main trends on the company's businesses. The company has based the following discussion on its financial statements. You should read such discussion together with the company's financial statements.

    Forward Looking Statements

    This announcement contains statements that constitute "forward‑looking statements", many of which can be identified by the use of forward‑looking words such as "anticipate", "believe", "could", "expect", "should", "plan", "intend", "estimate", "strive", "forecast", "targets" and "potential", among others. The company is relying on the safe harbor provided in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in making such forward-looking statements.

    Forward‑looking statements appear in a number of places in this announcement and include, but are not limited to, statements regarding the company intent, belief or current expectations. Forward‑looking statements are based on the company management's beliefs and assumptions and on information currently available to the company management. Such statements are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward‑looking statements due to various factors, including, but not limited to:

    Changes in exchange rates or prices compared to those the company is currently experiencing; loss or impairment of business licenses or mineral extractions permits or concessions; volatility of supply and demand and the impact of competition; the difference between actual reserves and the company reserve estimates; natural disasters and cost of compliance with environmental regulatory legislative and licensing restrictions including laws and regulation related to, and physical impacts of climate change and greenhouse gas emissions; failure to "harvest" salt which could lead to accumulation of salt at the bottom of the evaporation Pond 5 in the Dead Sea; disruptions at the company seaport shipping facilities or regulatory restrictions affecting the company ability to export the company products overseas; general market, political or economic conditions in the countries in which the company operates, including tariffs and trade policies; price increases or shortages with respect to the company principal raw materials; delays in termination of engagements with contractors and/or governmental obligations; the inflow of significant amounts of water into the Dead Sea which could adversely affect production at the company plants; labor disputes, slowdowns and strikes involving the company employees; pension and health insurance liabilities; pandemics may create disruptions, impacting the company sales, operations, supply chain and customers; changes to governmental incentive programs or tax benefits, creation of new fiscal or tax related legislation; and/or higher tax liabilities; changes in the company evaluations and estimates, which serve as a basis for the recognition and manner of measurement of assets and liabilities; failure to integrate or realize expected benefits from mergers and acquisitions, organizational restructuring and joint ventures; currency rate fluctuations; rising interest rates; government examinations or investigations; disruption of the company, or the company service providers', information technology systems or breaches of the company, or the company service providers', data security; failure to retain and/or recruit key personnel; inability to realize expected benefits from the company cost reduction program according to the expected timetable; inability to access capital markets on favorable terms; cyclicality of the company businesses; changes in demand for the company fertilizer products due to a decline in agricultural product prices, lack of available credit, weather conditions, government policies or other factors beyond the company control; sales of the company magnesium products being affected by various factors that are not within the company control; the company ability to secure approvals and permits from the authorities in Israel to continue the company phosphate mining operations in Rotem Amfert Israel; volatility or crises in the financial markets; hazards inherent to mining and chemical manufacturing; the failure to ensure the safety of the company workers and processes; litigation, arbitration and regulatory proceedings; exposure to third party and product liability claims; product recalls or other liability claims as a result of food safety and food-borne illness concerns; insufficiency of insurance coverage; closing of transactions, mergers and acquisitions; war or acts of terror and/or political, economic and military instability in Israel and its region; including the current state of war declared in Israel and any resulting disruptions to the company supply and production chains; filing of class actions and derivative actions against the company, its executives and Board members; The company is exposed to risks relating to its current and future activity in emerging markets; and other risk factors discussed under "Item 3 - Key Information— D. Risk Factors" in the company's Annual Report on Form 20-F for the year ended December 31, 2024, filed with the U.S. Securities and Exchange Commission (the "SEC") on March 13, 2025 (the "Annual Report").

    Forward-looking statements speak only as of the date they are made, and the company does not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events. Investors are cautioned to consider these risks and uncertainties and to not place undue reliance on such information. Forward-looking statements should not be read as a guarantee of future performance or results and are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward-looking statements.

    This announcement for the first quarter of 2025 should be read in conjunction with the Annual Report of 2024 published by the company on Form 20-F, as of and for the year ended December 31, 2024, including the description of the events occurring subsequent to the date of the statement of financial position, as filed with the US SEC.

    Appendix

    Condensed Consolidated Statements of Income (Unaudited)

         

    $ millions

     

    Three-months ended

     

    Year ended

     

    March 31,

    2025

     

    March 31,

    2024

     

    December 31,

    2024

    Sales

     

    1,767

     

    1,735

     

    6,841

    Cost of sales

     

    1,207

     

    1,178

     

    4,585

     

     

     

     

     

     

     

    Gross profit

     

    560

     

    557

     

    2,256

     

     

     

     

     

     

     

    Selling, transport and marketing expenses

     

    268

     

    273

     

    1,114

    General and administrative expenses

     

    77

     

    64

     

    259

    Research and development expenses

     

    18

     

    17

     

    69

    Other expenses

     

    16

     

    3

     

    60

    Other income

     

    (4)

     

    (3)

     

    (21)

     

     

     

     

     

     

     

    Operating income

     

    185

     

    203

     

    775

     

     

     

     

     

     

     

    Finance expenses

     

    62

     

    60

     

    181

    Finance income

     

    (25)

     

    (25)

     

    (41)

    Finance expenses, net

     

    37

     

    35

     

    140

     

     

     

     

     

     

     

    Share in earnings of equity-accounted investees

     

    -

     

    -

     

    1

     

     

     

     

     

     

     

    Income before taxes on income

     

    148

     

    168

     

    636

     

     

     

     

     

     

     

    Taxes on income

     

    42

     

    42

     

    172

     

     

     

     

     

     

     

    Net income

     

    106

     

    126

     

    464

     

     

     

     

     

     

     

    Net income attributable to the non-controlling interests

     

    15

     

    17

     

    57

     

     

     

     

     

     

     

    Net income attributable to the shareholders of the Company

     

    91

     

    109

     

    407

     

     

     

     

     

     

     

    Earnings per share attributable to the shareholders of the Company:

     

     

     

     

     

     

     

     

     

     

     

     

     

    Basic earnings per share (in dollars)

     

    0.07

     

    0.08

     

    0.32

     

     

     

     

     

     

     

    Diluted earnings per share (in dollars)

     

    0.07

     

    0.08

     

    0.32

     

     

     

     

     

     

     

    Weighted-average number of ordinary shares outstanding:

     

     

     

     

     

     

     

     

     

     

     

     

     

    Basic (in thousands)

     

    1,290,452

     

    1,289,530

     

    1,289,968

     

     

     

     

     

     

     

    Diluted (in thousands)

     

    1,290,944

     

    1,290,362

     

    1,290,039

     

    Condensed Consolidated Statements of Financial Position as of (Unaudited)

     

    $ millions

    March 31,

    2025

    March 31,

    2024

    December 31,

    2024

    Current assets

     

     

     

     

     

     

    Cash and cash equivalents

     

    312

     

    363

     

    327

    Short-term investments and deposits

     

    121

     

    121

     

    115

    Trade receivables

     

    1,497

     

    1,492

     

    1,260

    Inventories

     

    1,629

     

    1,630

     

    1,626

    Prepaid expenses and other receivables

     

    277

     

    301

     

    258

    Total current assets

     

    3,836

     

    3,907

     

    3,586

     

     

     

     

     

     

     

    Non-current assets

     

     

     

     

     

     

    Deferred tax assets

     

    151

     

    155

     

    143

    Property, plant and equipment

     

    6,526

     

    6,285

     

    6,462

    Intangible assets

     

    918

     

    897

     

    869

    Other non-current assets

     

    260

     

    242

     

    261

    Total non-current assets

     

    7,855

     

    7,579

     

    7,735

     

     

     

     

     

     

     

    Total assets

     

    11,691

     

    11,486

     

    11,321

     

     

     

     

     

     

     

    Current liabilities

     

     

     

     

     

     

    Short-term debt

     

    570

     

    623

     

    384

    Trade payables

     

    1,031

     

    914

     

    1,002

    Provisions

     

    62

     

    54

     

    63

    Other payables

     

    940

     

    849

     

    879

    Total current liabilities

     

    2,603

     

    2,440

     

    2,328

     

     

     

     

     

     

     

    Non-current liabilities

     

     

     

     

     

     

    Long-term debt and debentures

     

    1,856

     

    1,883

     

    1,909

    Deferred tax liabilities

     

    486

     

    492

     

    481

    Long-term employee liabilities

     

    333

     

    352

     

    331

    Long-term provisions and accruals

     

    229

     

    218

     

    230

    Other

     

    61

     

    57

     

    55

    Total non-current liabilities

     

    2,965

     

    3,002

     

    3,006

     

     

     

     

     

     

     

    Total liabilities

     

    5,568

     

    5,442

     

    5,334

     

     

     

     

     

     

     

    Equity

     

     

     

     

     

     

    Total shareholders' equity

     

    5,844

     

    5,762

     

    5,724

    Non-controlling interests

     

    279

     

    282

     

    263

    Total equity

     

    6,123

     

    6,044

     

    5,987

     

     

     

     

     

     

     

    Total liabilities and equity

     

    11,691

     

    11,486

     

    11,321

     

    Condensed Consolidated Statements of Cash Flows (Unaudited)

     

    $ millions

    Three-months ended

    Year ended

    March 31,

    2025

    March 31,

    2024

    December 31,

    2024

    Cash flows from operating activities

     

     

     

     

     

     

    Net income

     

    106

     

    126

     

    464

    Adjustments for:

     

     

     

     

     

     

    Depreciation and amortization

     

    151

     

    147

     

    596

    Fixed assets impairment

     

    -

     

    -

     

    14

    Exchange rate, interest and derivative, net

     

    44

     

    59

     

    152

    Tax expenses

     

    42

     

    42

     

    172

    Change in provisions

     

    (5)

     

    (42)

     

    (50)

    Other

     

    3

     

    2

     

    13

     

     

    235

     

    208

     

    897

     

     

     

     

     

     

     

    Change in inventories

     

    28

     

    51

     

    (7)

    Change in trade receivables

     

    (202)

     

    (141)

     

    26

    Change in trade payables

     

    31

     

    26

     

    104

    Change in other receivables

     

    (15)

     

    18

     

    39

    Change in other payables

     

    18

     

    10

     

    43

    Net change in operating assets and liabilities

     

    (140)

     

    (36)

     

    205

     

     

     

     

     

     

     

    Income taxes paid, net of refund

     

    (36)

     

    (6)

     

    (98)

     

     

     

     

     

     

     

    Net cash provided by operating activities (*)

     

    165

     

    292

     

    1,468

     

     

     

     

     

     

     

    Cash flows from investing activities

     

     

     

     

     

     

    Proceeds (payments) from deposits, net

     

    (4)

     

    50

     

    56

    Purchases of property, plant and equipment and intangible assets

     

    (190)

     

    (145)

     

    (713)

    Proceeds from divestiture of assets and businesses, net of transaction expenses

     

    2

     

    15

     

    19

    Interest received (*)

     

    3

     

    7

     

    17

    Business combinations

     

    (3)

     

    (22)

     

    (74)

    Other

     

    -

     

    -

     

    1

    Net cash used in investing activities

     

    (192)

     

    (95)

     

    (694)

     

     

     

     

     

     

     

    Cash flows from financing activities

     

     

     

     

     

     

    Dividends paid to the Company's shareholders

     

    (52)

     

    (61)

     

    (251)

    Receipts of long-term debt

     

    361

     

    198

     

    889

    Repayments of long-term debt

     

    (397)

     

    (386)

     

    (1,302)

    Receipts (repayments) of short-term debt

     

    109

     

    17

     

    (1)

    Interest paid (*)

     

    (16)

     

    (20)

     

    (122)

    Receipts (payments) from transactions in derivatives

     

    -

     

    3

     

    (2)

    Dividend paid to the non-controlling interests

     

    -

     

    -

     

    (57)

    Net cash provided by (used in) financing activities

     

    5

     

    (249)

     

    (846)

     

     

     

     

     

     

     

    Net change in cash and cash equivalents

     

    (22)

     

    (52)

     

    (72)

    Cash and cash equivalents as of the beginning of the period

     

    327

     

    420

     

    420

    Net effect of currency translation on cash and cash equivalents

     

    7

     

    (5)

     

    (21)

    Cash and cash equivalents as of the end of the period

     

    312

     

    363

     

    327

     

    (*) Reclassified - see Note 2(b) to the Company's Interim Financial Statements.

    Adjustments to Reported Operating and Net Income (non-GAAP)

     

    $ millions

    Three-months ended

     

    March 31,

    2025

     

    March 31,

    2024

    Operating income

     

    185

     

    203

    Charges related to the security situation in Israel (1)

     

    10

     

    12

    Fire incident at Ashdod Port (2)

     

    4

     

    -

    Provision for early retirement (3)

     

    9

     

    -

    Total adjustments to operating income

     

    23

     

    12

    Adjusted operating income

     

    208

     

    215

    Net income attributable to the shareholders of the Company

     

    91

     

    109

    Total adjustments to operating income

     

    23

     

    12

    Total tax adjustments (4)

     

    (4)

     

    (3)

    Total adjusted net income - shareholders of the Company

     

    110

     

    118

     

    (1)

    For 2025 and 2024, reflects charges relating to the security situation in Israel.

    (2)

    For 2025, reflects expenses related to the fire incident at Ashdod Port.

    (3)

    For 2025, reflects provisions for early retirement, due to restructuring at certain sites, as part of the Company's global efficiency plan.

    (4)

    For 2025 and 2024, reflects the tax impact of adjustments made to operating income.

    Consolidated EBITDA for the Periods of Activity

     

    $ millions

    Three-months ended

     

    March 31,

    2025

     

    March 31,

    2024

    Net income

     

    106

     

    126

    Financing expenses, net

     

    37

     

    35

    Taxes on income

     

    42

     

    42

    Less: Share in earnings of equity-accounted investees

     

    -

     

    -

    Operating income

     

    185

     

    203

    Depreciation and amortization

     

    151

     

    147

    Adjustments (1)

     

    23

     

    12

    Total adjusted EBITDA

     

    359

     

    362

     

    (1) See "Adjustments to Reported Operating and Net income (non-GAAP)" above.

    Calculation of Segment EBITDA

    $ millions

    Industrial

    Products

    Potash

    Phosphate

    Solutions (1)

    Growing Solutions

    Three-months ended

    March 31, 2025

    March 31, 2024

    March 31, 2025

    March 31, 2024

    March 31, 2025

    March 31, 2024

    March 31, 2025

    March 31, 2024

    Segment operating income

     

    62

     

    59

     

    56

     

    62

     

    91

     

    84

     

    28

     

    23

    Depreciation and amortization

     

    14

     

    13

     

    62

     

    62

     

    48

     

    47

     

    19

     

    19

    Segment EBITDA

     

    76

     

    72

     

    118

     

    124

     

    139

     

    131

     

    47

     

    42

     

    (1)

    For the first quarter of 2025, Phosphate Specialties accounted for $324 million of segment sales, $39 million of operating income, $12 million of D&A and $51 million of EBITDA, while Phosphate Commodities accounted for $249 million of segment sales, $52 million of operating income, $36 million of D&A and represented $88 million of EBITDA.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250517057266/en/

    Investor and Press Contact – Global

    Peggy Reilly Tharp

    VP, Global Investor Relations

    +1-314-983-7665

    [email protected]



    Investor and Press Contact - Israel

    Adi Bajayo

    ICL Spokesperson

    +972-3-6844459

    [email protected]

    Get the next $ICL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ICL

    DatePrice TargetRatingAnalyst
    1/21/2025$4.00 → $6.00Underweight → Equal Weight
    Barclays
    1/12/2024$6.50 → $4.00Overweight → Underweight
    Barclays
    11/14/2023$7.00 → $6.50Equal Weight → Overweight
    Barclays
    5/18/2023Buy → Neutral
    BofA Securities
    6/1/2022$12.00Equal Weight
    Barclays
    2/14/2022$9.00 → $10.00Equal-Weight
    Morgan Stanley
    12/6/2021$7.00 → $9.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $ICL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ICL Group upgraded by Barclays with a new price target

      Barclays upgraded ICL Group from Underweight to Equal Weight and set a new price target of $6.00 from $4.00 previously

      1/21/25 7:50:33 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Group downgraded by Barclays with a new price target

      Barclays downgraded ICL Group from Overweight to Underweight and set a new price target of $4.00 from $6.50 previously

      1/12/24 6:56:19 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Group upgraded by Barclays with a new price target

      Barclays upgraded ICL Group from Equal Weight to Overweight and set a new price target of $6.50 from $7.00 previously

      11/14/23 7:37:49 AM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ICL Reports First Quarter 2025 Results

      Sales of $1.8 billion increased year-over-year, with operating income of $185 million, adjusted EBITDA of $359 million and adjusted diluted EPS of $0.09 ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the first quarter ended March 31, 2025. Consolidated sales were $1.8 billion versus $1.7 billion in the prior year. Operating income was $185 million versus $203 million of operating income in the first quarter of last year, with adjusted operating income of $208 million versus $215 million. For the first quarter, net income attributable to shareholders was $91 million versus $109 million in the prior year, with adjusted net in

      5/19/25 1:10:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Announces First Quarter 2025 Earnings Call

      ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter 2025 results prior to the opening of the TASE market on Monday, May 19, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (800) 549-8228, or (646) 564-2877 for international analysts, and the conference ID is ICL. To participate, please dial in a few minutes before the scheduled time. Employees,

      4/23/25 8:00:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • Israel Corp. Reports Results for Fourth Quarter of 2024

      TEL AVIV, Israel, March 27, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its fourth quarter and annual results for the period ending December 31, 2024. Selected Financial Figures for the Fourth Quarter 2024: $m Q3/24 Q3/23 2024 2023 ILCO share in ICL profit1 30 28 175 282 Financing, G&A and other at ILCO headquarter level  2 1 - (8) Tax income (expense) of ILCO Headquarters (1) (1) 15 (1) Net profit to company's shareholders 31 28 190 273 Liquidity at the ILCO Headquarters Level2 As of December 31, 2024, total financial liabilities were $733 million, and investments in liquid assets amounted to $882 million of which $83 million are pledged deposits. Net

      3/27/25 5:48:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    SEC Filings

    See more
    • SEC Form 6-K filed by ICL Group Ltd.

      6-K - ICL Group Ltd. (0000941221) (Filer)

      5/20/25 4:20:09 PM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form 6-K filed by ICL Group Ltd.

      6-K - ICL Group Ltd. (0000941221) (Filer)

      5/19/25 2:51:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form 6-K filed by ICL Group Ltd.

      6-K - ICL Group Ltd. (0000941221) (Filer)

      5/19/25 6:50:24 AM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by ICL Group Ltd.

      SC 13G/A - ICL Group Ltd. (0000941221) (Subject)

      11/14/24 6:11:02 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form SC 13G filed by ICL Group Ltd.

      SC 13G - ICL Group Ltd. (0000941221) (Subject)

      1/31/24 6:05:59 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form SC 13G/A filed by ICL Group Ltd. (Amendment)

      SC 13G/A - ICL Group Ltd. (0000941221) (Subject)

      1/30/24 8:10:40 AM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Financials

    Live finance-specific insights

    See more
    • ICL Reports First Quarter 2025 Results

      Sales of $1.8 billion increased year-over-year, with operating income of $185 million, adjusted EBITDA of $359 million and adjusted diluted EPS of $0.09 ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the first quarter ended March 31, 2025. Consolidated sales were $1.8 billion versus $1.7 billion in the prior year. Operating income was $185 million versus $203 million of operating income in the first quarter of last year, with adjusted operating income of $208 million versus $215 million. For the first quarter, net income attributable to shareholders was $91 million versus $109 million in the prior year, with adjusted net in

      5/19/25 1:10:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Announces First Quarter 2025 Earnings Call

      ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter 2025 results prior to the opening of the TASE market on Monday, May 19, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (800) 549-8228, or (646) 564-2877 for international analysts, and the conference ID is ICL. To participate, please dial in a few minutes before the scheduled time. Employees,

      4/23/25 8:00:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • Israel Corp. Reports Results for Fourth Quarter of 2024

      TEL AVIV, Israel, March 27, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its fourth quarter and annual results for the period ending December 31, 2024. Selected Financial Figures for the Fourth Quarter 2024: $m Q3/24 Q3/23 2024 2023 ILCO share in ICL profit1 30 28 175 282 Financing, G&A and other at ILCO headquarter level  2 1 - (8) Tax income (expense) of ILCO Headquarters (1) (1) 15 (1) Net profit to company's shareholders 31 28 190 273 Liquidity at the ILCO Headquarters Level2 As of December 31, 2024, total financial liabilities were $733 million, and investments in liquid assets amounted to $882 million of which $83 million are pledged deposits. Net

      3/27/25 5:48:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Leadership Updates

    Live Leadership Updates

    See more
    • ICL Announces Appointment of Elad Aharonson as New President and Chief Executive Officer

      ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced its Board of Directors has approved the appointment of Elad Aharonson as ICL's new president and chief executive officer, effective March 13, 2025. He will succeed Raviv Zoller who will work with Aharonson to ensure a smooth and orderly transition. Elad Aharonson has been an integral part of ICL for nearly four years, serving as president of ICL's Growing Solutions business since April of 2021. During his tenure, he led the development of ICL's specialty fertilizer solutions and the expansion of these product offerings into new territories, through both organic efforts and via acquisitions. His signif

      12/23/24 2:10:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Announces Planned Departure of President and CEO Raviv Zoller

      Zoller to continue to serve the company until a replacement has been announced ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced that Raviv Zoller, the company's president and CEO for the past seven years, is expected to leave the company in early 2025, following both the appointment of a replacement and a formal transition. In a letter to the company's employees, Zoller wrote, "I feel great pride, mixed with sorrow, as I announce my expected retirement from the position as president and CEO of ICL. Over the past seven years at this amazing organization, I have come to know our employees who give their heart and soul to the company. Together, we ha

      12/5/24 7:21:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Recognized by Fortune as a Company That is Changing the World

      Company's Agmatix AI-driven data platform and RegenIQ framework designated as a Friend of Farmers ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced that Agmatix, the company's ag tech digital start-up, has been named to Fortune's 10th Annual Change the World list. The list recognizes companies that have had a positive social impact through activities that are part of their core business strategy. Among other factors, nominees are assessed on their measurable impact on people and the planet, profitability related to their impactful work, and the degree of innovation they have demonstrated. Agmatix was recognized for its AI-driven platform, which helps

      10/15/24 4:15:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials